跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
DOXABIN INJECTION 2MG/ML - HSA Drug Approval Details
Approvals
/
HSA
/
DOXABIN INJECTION 2MG/ML
Approved
THERAPEUTIC
DOXABIN INJECTION 2MG/ML
MYLAN LABORATORIES LIMITED [OTL] (INDIA)
🇸🇬 Health Sciences Authority
Approval Date
Oct 30, 2012
Approval ID
526c480b146709b1
Company
MYLAN LABORATORIES LIMITED [OTL] (INDIA)
Type
Therapeutic
Approval Details
Approval Id
526c480b146709b1
Drug Name
DOXABIN INJECTION 2MG/ML
Product Name
DOXABIN INJECTION 2MG/ML
Approval Number
SIN14262P
Approval Date
2012-10-30
Registrant
VIATRIS PHARMACEUTICALS PTE. LTD.
Licence Holder
VIATRIS PHARMACEUTICALS PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INJECTION, SOLUTION
Route Of Administration
INTRAVENOUS, INTRAVESICAL
Atc Code
L01DB01
Atc Item Name
doxorubicin
Pharma Manufacturer Name
mylan pharmaceuticals pte. ltd.
Active Ingredients
Doxorubicin Hydrochloride
2mg/ml
DOXORUBICIN HYDROCHLORIDE
2 MG/ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Oct 30, 2012
Approval ID
526c480b146709b1
Type
Therapeutic
Back to HSA Approvals